A diametric role for OX40 in the response of effector/memory CD4+ T cells and regulatory T cells to alloantigen

OX40 is a member of the TNFR superfamily that has potent costimulatory properties. Although the impact of blockade of the OX40-OX40 ligand (OX40L) pathway has been well documented in models of autoimmune disease, its effect on the rejection of allografts is less well defined. In this article, we sho...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of immunology (1950) Vol. 191; no. 3; pp. 1465 - 1475
Main Authors Kinnear, Gillian, Wood, Kathryn J, Fallah-Arani, Farnaz, Jones, Nick D
Format Journal Article
LanguageEnglish
Published United States 01.08.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:OX40 is a member of the TNFR superfamily that has potent costimulatory properties. Although the impact of blockade of the OX40-OX40 ligand (OX40L) pathway has been well documented in models of autoimmune disease, its effect on the rejection of allografts is less well defined. In this article, we show that the alloantigen-mediated activation of naive and memory CD4(+) T cells results in the induction of OX40 expression and that blockade of OX40-OX40L interactions prevents skin allograft rejection mediated by either subset of T cells. Moreover, a blocking anti-OX40 had no effect on the activation and proliferation of T cells; rather, effector T cells failed to accumulate in peripheral lymph nodes and subsequently migrate to skin allografts. This was found to be the result of an enhanced degree of cell death among proliferating effector cells. In clear contrast, blockade of OX40-OX40L interactions at the time of exposure to alloantigen enhanced the ability of regulatory T cells to suppress T cell responses to alloantigen by supporting, rather than diminishing, regulatory T cell survival. These data show that OX40-OX40L signaling contributes to the evolution of the adaptive immune response to an allograft via the differential control of alloreactive effector and regulatory T cell survival. Moreover, these data serve to further highlight OX40 and OX40L as therapeutic targets to assist the induction of tolerance to allografts and self-Ags.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
Address: MRC Centre for Immune Regulation, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, B15 2TT.
ISSN:0022-1767
1550-6606
DOI:10.4049/jimmunol.1300553